Tirzepatide is a dual GIP and GLP-1 receptor agonist, targeting two incretin pathways simultaneously
IGF-1 LR3 should not exceed 28 days
The information on DrRuscio.com is for educational purposes only
A commenter expressed concern that including spending on necessary services in EBCMs could inadvertently reward clinicians for reducing spending on essential care, potentially leading to worse patient outcomes that may not be reflected in quality measures, noting that average spending on patients could increase due to factors outside a clinician's control, such as rising drug prices or services ordered by other physicians, which could unfairly penalize clinicians
Additionally, it is important to note that using too much bacteriostatic water can cause adverse effects on some peptides
Because the shot is fast and performed by trained staff, many patients find that the convenience outweighs any temporary discomfort